Asia IP - Intellectual Property News and Analysis
Search Result
Chinese Pharmaceutical Landscape Poised for IP and Other Regulatory Changes
2017 could easily be one of the most impactful years for pharmaceutical development in China, d...
Best Feature: The Shape of Pharma
Hosted by Johnny Chan, this academy award winning article reveals everything from protection to ...
The Way of Pharma’s Future
Johnny Chan examines the future of pharma in India and Taiwan.
The Curious Case of India and Big Pharma
Amid criticism from the United States and elsewhere, India has debuted its first national IP policy....
Success Story Turns Bleak for Compulsory License: A Report
What are the compulsory license proceedings of Lee Pharma for saxagliptin?
Recent PRB Decisions on Pharma and Biotech Inventions
China’s Patent Reexamination Board plays an important role in determining what can be patented...